ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 258625 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 258625; 2) Community: the network communities that were significantly associated with the response to NSC 258625; 3) Molecule: the relationships between components within communities and NSC 258625; 4) MDR: the compounds that were significantly associated with the NSC 258625.

NSC Compound Enrichment Correlation
NSC 727012 (2S,3S)-3,4-Epoxy-2-(3-methoxy-5-methyl-1-naphthoyloxy)-3-methylbutanamide 0.0202245331784479 0.32190916
NSC 727985 NSC 708781 incorporated in micelles, 0.55% (w/w) of drug 0.0202245331784479 0.043428196
NSC 730460 16-[4-{(3-Imidazol-1-yl)propoxy}-3-methoxybenzylidene]-3b-py rrolidino-5-androsten-17b-YL acetate 0.0202245331784479 0.50752322
NSC 735407 Null 0.0202245331784479 0.20757161
NSC 746248 Null 0.0202245331784479 -0.0013091339
NSC 761997 Null 0.0202245331784479 0.095431097
NSC 321206 Null 0.0220039422291538 0.44335662
NSC 33577 Null 0.0220039422291538 0.22351069
NSC 603086 2-Butene, 2,3-dibromo-1,4-bis[(3,4-dichloro-2,5-dihydro- 2-oxofuran-5-yl)oxy]-, (Z)- 0.0220039422291538 0.56331682
NSC 617823 4-Morpholinepentanoic acid, .alpha.-(phenylmethylene)- .beta.-oxo-, ethyl ester, hydrochloride 0.0220039422291538 0.64250867
Total:91  Current:44    [First] [Prev] [Next] [Last]